This compound is a deuterated purine derivative and an active pharmaceutical ingredient. It is characterized by a complex heterocyclic structure, incorporating a piperidine ring and a quinazoline moiety, and is used in pharmaceutical manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1398044-48-8
(+/-)-Phenoxybenzamine-d5 HCl (benzyl-2,3,4,5,6-d5)
pharmaceutical raw material
Rac Atomoxetine-d5 Hydrochloride
pharmaceutical raw material
Urapidil-d3 (methoxy-d3)
pharmaceutical raw material
Sarolaner
pharmaceutical raw material
LINAGLIPTIN, (S)-
pharmaceutical raw material
Linagliptin
pharmaceutical raw material
[(3R)-1-[7-(2-Butynyl)-2,3,6,7-tetrahydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]carbamic acid 1,1-dimethylethyl ester
pharmaceutical intermediate
8-[(3R)-3-aminopiperidin-1-yl]-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-7-(4,4,4-trideuteriobut-2-ynyl)purine-2,6-dione
LTXREWYXXSTFRX-JCNGFBMWSA-N
[2H]C([2H])([2H])C#CCN1C2=C(N=C1N3CCC[C@H](C3)N)N(C(=O)N(C2=O)CC4=NC5=CC=CC=C5C(=N4)C)C
—